Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: LABORATOIRE HRA PHARMA, 200 avenue de Paris, 92320, CHATILLON, France
ellaOne 30 mg tablet.
| Pharmaceutical Form |
|---|
|
Tablet. White to marble creamy, round curved tablet of 9 mm diameter engraved with “ะตllะฐ” on both sides. |
Each tablet contains 30 mg ulipristal acetate.
Excipients with known effect: Each tablet contains 237 mg of lactose (as monohydrate).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ulipristal |
Ulipristal is an orally-active synthetic selective progesterone receptor modulator which acts via high-affinity binding to the human progesterone receptor. When used for emergency contraception the mechanism of action is inhibition or delay of ovulation via suppression of the luteinising hormone (LH) surge. Pharmacodynamic data show that even when taken immediately before ovulation is scheduled to occur (when LH has already started to rise), ulipristal acetate is able to postpone follicular rupture for at least 5 days. |
| List of Excipients |
|---|
|
Lactose monohydrate |
PVC-PE-PVDC-Aluminium blister of 1 tablet.
PVC-PVDC-Aluminium blister of 1 tablet.
Each carton contains one blister.
Not all pack sizes may be marketed.
LABORATOIRE HRA PHARMA, 200 avenue de Paris, 92320, CHATILLON, France
EU/1/09/522/001
EU/1/09/522/002
Date of first authorisation: 15 May 2009
Date of latest renewal: 21 March 2014
| Drug | Countries | |
|---|---|---|
| ELLAONE | Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Lithuania, Netherlands, Poland, Romania, Tunisia, United Kingdom |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
